Literature DB >> 19774624

Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.

Marijana Stanojevic1, Svetlana Savin, Dubravka Cvejic, Aleksandar Djukic, Marija Jeremic, Snezana Zivancević Simonovic.   

Abstract

Measurement of serum thyroglobulin (Tg) is a highly specific test in the management of patients with differentiated thyroid cancer (DTC) after surgical treatment. The aim of our study was to evaluate and compare Tg levels in these patients found by radioimmunoassay (RIA) and immunoradiometric assay (IRMA) and to assess the influence of Tg antibodies (TgAbs) on the values obtained for Tg concentration. Both Tg and TgAb were determined postoperatively in the serum of 71 DTC patients using RIA Tg-PEG (INEP) and Tg IRMA (CIS) for Tg, together with TgAb (CIS) for circulating endogenous anti-TgAbs. The obtained concentrations were evaluated statistically. We found a significant difference of Tg concentrations between paired samples from the IRMA and RIA, although the intermethod comparison yielded satisfactory concordance of the two assays (Spearman correlation coefficient -0.792). Positive TgAb was found in 28.2% of the serum samples analyzed. Spearman rank correlation analysis revealed a significant negative relationship between serum TgAb and Tg level measured by IRMA (P=0.02), but not by RIA (P=0.417). On the other hand, our clinical data revealed that 1/18 and 3/18 patients with proven lymph node metastasis had Tg values below the detection limit by RIA and IRMA assay, respectively. Their sera were TgAb positive. We concluded that RIA was less prone to influence of TgAb than IRMA. As the presence of TgAbs may interfere in Tg measurement irrespective of the method selected for determination, this should be considered during the clinical management of these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19774624      PMCID: PMC6649009          DOI: 10.1002/jcla.20339

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Can we measure serum thyroglobulin?

Authors:  P M Clark; G Beckett
Journal:  Ann Clin Biochem       Date:  2002-05       Impact factor: 2.057

2.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

3.  Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma.

Authors:  A Kumar; D H Shah; U Shrihari; S R Dandekar; U Vijayan; S M Sharma
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

4.  Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study.

Authors:  D Rubello; D Casara; M E Girelli; M Piccolo; B Busnardo
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

5.  European interlaboratory comparison of serum thyroglobulin measurement.

Authors:  U Feldt-Rasmussen; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

6.  Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies?

Authors:  E G Black; R Hoffenberg
Journal:  Clin Endocrinol (Oxf)       Date:  1983-11       Impact factor: 3.478

7.  Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.

Authors:  B Schaadt; U Feldt-Rasmussen; B Rasmusson; H Tørring; B Foder; K Jørgensen; H S Hansen
Journal:  Thyroid       Date:  1995-06       Impact factor: 6.568

Review 8.  Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.

Authors:  C A Spencer; C C Wang
Journal:  Endocrinol Metab Clin North Am       Date:  1995-12       Impact factor: 4.741

9.  Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study.

Authors:  L A Tortajada-Genaro; M P Cózar; J L Moreno Frigols; C Romero de Avila
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

10.  Critical aspects of immunoradiometric thyroglobulin assays.

Authors:  Leonardo Ferrari; Donatella Biancolini; Ettore Seregni; Gianluca Aliberti; Antonia Martinetti; Carlo Villano; Federica Pallotti; Carlo Chiesa; Emilio Bombardieri
Journal:  Tumori       Date:  2003 Sep-Oct
View more
  7 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  Thyroglobulin as a biomarker of iodine deficiency: a review.

Authors:  Zheng Feei Ma; Sheila A Skeaff
Journal:  Thyroid       Date:  2014-06-12       Impact factor: 6.568

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

4.  Comparison of Serum Thyroglobulin Levels in Differentiated Thyroid Cancer Patients Using In-House Developed Radioimmunoassay and Immunoradiometric Procedures.

Authors:  Chandrakala Gholve; J Kumarasamy; Archana Damle; Savita Kulkarni; Meera Venkatesh; Sharmila Banerjee; M G R Rajan
Journal:  Indian J Clin Biochem       Date:  2018-06-18

Review 5.  How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.

Authors:  Carole Spencer; Jonathan LoPresti; Shireen Fatemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

6.  Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.

Authors:  Qiang Jia; Zhaowei Meng; Ke Xu; Xianghui He; Jian Tan; Guizhi Zhang; Xue Li; Na Liu; Tianpeng Hu; Pingping Zhou; Sen Wang; Arun Upadhyaya; Xiaoxia Liu; Huiying Wang; Chunmei Zhang
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

Review 7.  Prevalence of Neural Autoantibodies in Epilepsy of Unknown Etiology: Systematic Review and Meta-Analysis.

Authors:  Pablo Cabezudo-García; Natalia Mena-Vázquez; Nicolás L Ciano-Petersen; Guillermina García-Martín; Guillermo Estivill-Torrús; Pedro J Serrano-Castro
Journal:  Brain Sci       Date:  2021-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.